Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadao Ohno

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Radiation Oncology (London, England)|October 18, 2013
A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinomaMasato Abei, Toshiyuki Okumura, Kuniaki Fukuda, et al.
Journal of Neurosurgery|May 17, 2011
Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma. Clinical articleYoshihiro Muragaki, Takashi Maruyama, Hiroshi Iseki, et al.
Japanese Journal of Clinical Oncology|May 16, 2025
A randomized, placebo-controlled phase III trial of an autologous, formalin-fixed tumor vaccine for newly diagnosed glioblastoma: trial protocolYoshihiro Muragaki, Eiichi Ishikawa, Manabu Tamura, et al.
Journal of Neurosurgery|January 21, 2023
A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomasYoshihiro Muragaki, Eiichi Ishikawa, Takashi Maruyama, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Radiation Oncology (London, England)|October 18, 2013
A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinomaMasato Abei, Toshiyuki Okumura, Kuniaki Fukuda, et al.
Journal of Neurosurgery|May 17, 2011
Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma. Clinical articleYoshihiro Muragaki, Takashi Maruyama, Hiroshi Iseki, et al.
Japanese Journal of Clinical Oncology|May 16, 2025
A randomized, placebo-controlled phase III trial of an autologous, formalin-fixed tumor vaccine for newly diagnosed glioblastoma: trial protocolYoshihiro Muragaki, Eiichi Ishikawa, Manabu Tamura, et al.
Journal of Neurosurgery|January 21, 2023
A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomasYoshihiro Muragaki, Eiichi Ishikawa, Takashi Maruyama, et al.
Pageof 6